chlorthalidone has been researched along with labetalol in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (60.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (26.67) | 29.6817 |
2010's | 2 (13.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
De Chătel, R; Flammer, J; Reubi, F; Weidmann, P; Ziegler, WH | 1 |
Cherchi, A; Pirisi, R; Pisano, MR; Raffo, M; Sau, F; Seguro, C | 1 |
Cumetti, C; De Cristofaro, A; Montanari, C; Roja, M; Vergani, A | 1 |
Dal Negro, RW; Pomari, C; Trevisan, F; Turco, P; Zoccatelli, O | 1 |
Evsikov, EM; Kharchenko, VI; Liusov, VA; Mart'ianova, II; Shcheplikova, TM | 1 |
Avantaggiato, F; Balestrazzi, M; Chiarappa, R; De Cesaris, R; Grimaldi, A; Ranieri, G | 1 |
Evsikov, EM; Istomina, IA; Kharchenko, VI; Liusov, VA; Rifai, MA | 1 |
Baretta, G; Berto, R; Buniotto, P; Cogo, L; Lechi, A; Marini, F; Parrinello, A; Pomari, S; Tomasi, A | 1 |
Rossi, AG | 1 |
1 review(s) available for chlorthalidone and labetalol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for chlorthalidone and labetalol
Article | Year |
---|---|
Alpha and beta adrenergic blockade with orally administered labetalol in hypertension. Studies on blood volume, plasma renin and aldosterone and catecholamine excretion.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Blood Volume; Body Weight; Chlorthalidone; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Epinephrine; Ethanolamines; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Norepinephrine; Potassium; Pulse; Renin | 1978 |
Respiratory effects of four adrenergic blocking agents combined with a diuretic in treating hypertension with concurrent chronic obstructive lung disease.
Topics: Adrenergic beta-Antagonists; Airway Resistance; Atenolol; Chlorthalidone; Drug Therapy, Combination; Forced Expiratory Volume; Humans; Hypertension; Labetalol; Lung Diseases, Obstructive; Male; Maximal Midexpiratory Flow Rate; Metoprolol; Oxprenolol; Random Allocation | 1986 |
Clinical evaluation of labetalol alone and combined with chlorthalidone in essential hypertension: a double-blind multicentre controlled study.
Topics: Adult; Blood Pressure; Chlorthalidone; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Ethanolamines; Female; Heart Rate; Humans; Hypertension; Labetalol; Male; Middle Aged | 1982 |
11 other study(ies) available for chlorthalidone and labetalol
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
[Effect of labetalol and chlorthalidone on exercise tolerance in hypertensive subjects].
Topics: Adult; Chlorthalidone; Ethanolamines; Exercise Test; Hemodynamics; Humans; Hypertension; Labetalol; Male; Middle Aged | 1979 |
Antihypertensive therapy with diuretics and beta-blockers at fixed dosage: comparison between the combinations labetalol plus chlorthalidone and atenolol plus chlorthalidone.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Chlorthalidone; Diuretics; Drug Therapy, Combination; Exercise Test; Heart Rate; Humans; Hypertension; Labetalol; Male | 1985 |
[Potentiation of the hypotensive effect of labetalol in hypertensive patients treated to maintain sodium balance in the body].
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Chlorthalidone; Combined Modality Therapy; Diet, Sodium-Restricted; Diuretics; Drug Synergism; Drug Therapy, Combination; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Vascular Resistance | 1987 |
Changes in blood pressure and thermographic values resulting from use of a beta-blocker plus diuretic and of an alpha-beta-blocker plus diuretic.
Topics: Adult; Atenolol; Body Temperature; Chlorthalidone; Drug Therapy, Combination; Heart Rate; Humans; Hypertension; Labetalol; Middle Aged; Thermography | 1985 |
[Changes in water-sodium balance in patients with hypertension subjected to different types of hypotensive therapy].
Topics: Adult; Aged; Aldosterone; Angiotensin I; Chlorthalidone; Extracellular Space; Female; Hemodynamics; Humans; Hypertension; Labetalol; Male; Middle Aged; Potassium; Sodium; Water-Electrolyte Balance | 1983 |
Use of the the combination labetalol plus chlorthalidone in essential arterial hypertension therapy.
Topics: Adult; Aged; Blood Pressure; Chlorthalidone; Drug Therapy, Combination; Ethanolamines; Female; Humans; Hypertension; Labetalol; Male; Middle Aged | 1981 |